Ciclosporin Inhibits Phorbol-Ester-Induced Hyperplastic Transformation and Tumor Promotion in Mouse Skin Probably by Suppression of Ca2+/Calmodulin-Dependent Processes such as Phosphorylation of Elongation Factor 2
作者:
M. Gschwendt,
W. Kittstein,
F. Marks,
期刊:
Skin Pharmacology and Physiology
(Karger Available online 1988)
卷期:
Volume 1,
issue 2
页码: 84-92
ISSN:1660-5527
年代: 1988
DOI:10.1159/000210753
出版商: S. Karger AG
关键词: Psoriasis;Phorbol ester;Epidermal hyperplasia;Calmodulin;Protein phosphorylation;Elongation factor 2;Tumor promotion;Mouse skin;Ciclosporin
数据来源: Karger
摘要:
This study deals with the mechanism of the inhibitory effect exerted by the immunosuppressant ciclosporin (CsA) on phorbol-ester-induced inflammation, epidermal hyperplasia and tumor promotion in mouse skin in vivo. This effect coincides with an inhibition of the phosphorylation of a 100-kilodalton protein (p 100) in epidermal cytosol in vitro, which has been identified as elongation factor 2 (EF-2) of protein biosynthesis. Phosphorylation of EF-2 is dependent on Ca2+ and calmodulin, and inhibition of EF-2 phosphorylation by CsA is due to an interaction of CsA with calmodulin. The EF-2 phosphorylation system has a metabolic half-life of 1.5 h probably due to a rather rapid turnover rate of the EF-2 kinase. Since CsA inhibits specifically 12–0-tetradecanoylphorbol-13-acetate (TPA)-stimulated but not basal protein synthesis in epidermis, it is proposed that Ca2+/calmodulin-dependent phosphorylation of EF-2 is involved in the induction of the hyperplastic response by TPA and that CsA suppresses TPA effects by inhibition of EF-2-phosphorylation and perhaps other calmodulin-dependent processes. The potential applicability of calmodulin inhibitors in the treatment of hyperproliferative skin diseases is discussed.
点击下载:
PDF
(1274KB)
返 回